🚀 VC round data is live in beta, check it out!
Anteris Technologies US Valuation Multiples
Discover revenue and EBITDA valuation multiples for Anteris Technologies US and similar public comparables like BrainsWay, Tactile Medical, Mesa Laboratories, Perspective Therapeutics and more.
Anteris Technologies US Overview
About Anteris Technologies US
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
Founded
2024
HQ
Employees
136
Website
Sectors
Financials (LTM)
EV
$526M
Anteris Technologies US Financials
Anteris Technologies US reported last 12-month revenue of $4M and negative EBITDA of ($95M).
In the same LTM period, Anteris Technologies US generated $2M in gross profit, ($95M) in EBITDA losses, and had net loss of ($98M).
Revenue (LTM)
Anteris Technologies US P&L
In the most recent fiscal year, Anteris Technologies US reported revenue of $2M and EBITDA of ($89M).
Anteris Technologies US expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4M | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | $2M | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | 53% | XXX | 70% | XXX | XXX | XXX |
| EBITDA | ($95M) | XXX | ($89M) | XXX | XXX | XXX |
| EBITDA Margin | (2467%) | XXX | (4671%) | XXX | XXX | XXX |
| EBIT Margin | (2556%) | XXX | (4921%) | XXX | XXX | XXX |
| Net Profit | ($98M) | XXX | ($94M) | XXX | XXX | XXX |
| Net Margin | (2545%) | XXX | (4921%) | XXX | XXX | XXX |
| Net Debt | — | — | $38K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Anteris Technologies US Stock Performance
Anteris Technologies US has current market cap of $537M, and enterprise value of $526M.
Market Cap Evolution
Anteris Technologies US's stock price is $5.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $526M | $537M | 1.1% | XXX | XXX | XXX | $-0.97 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAnteris Technologies US Valuation Multiples
Anteris Technologies US trades at 136.8x EV/Revenue multiple, and (5.5x) EV/EBITDA.
EV / Revenue (LTM)
Anteris Technologies US Financial Valuation Multiples
As of April 11, 2026, Anteris Technologies US has market cap of $537M and EV of $526M.
Equity research analysts estimate Anteris Technologies US's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Anteris Technologies US has a P/E ratio of (5.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $537M | XXX | $537M | XXX | XXX | XXX |
| EV (current) | $526M | XXX | $526M | XXX | XXX | XXX |
| EV/Revenue | 136.8x | XXX | 275.2x | XXX | XXX | XXX |
| EV/EBITDA | (5.5x) | XXX | (5.9x) | XXX | XXX | XXX |
| EV/EBIT | (5.4x) | XXX | (5.6x) | XXX | XXX | XXX |
| EV/Gross Profit | 259.1x | XXX | 391.7x | XXX | XXX | XXX |
| P/E | (5.5x) | XXX | (5.7x) | XXX | XXX | XXX |
| EV/FCF | (5.9x) | XXX | (6.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Anteris Technologies US Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Anteris Technologies US Margins & Growth Rates
Anteris Technologies US's revenue in the last 12 month grew by 168%.
Anteris Technologies US's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.7M for the same period.
Anteris Technologies US's rule of 40 is (853%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Anteris Technologies US's rule of X is (299%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Anteris Technologies US Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 168% | XXX | 369% | XXX | XXX | XXX |
| EBITDA Margin | (2467%) | XXX | (4671%) | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | 23% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (853%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (299%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1904% | XXX | 3638% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 4991% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Anteris Technologies US Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BrainsWay | XXX | XXX | XXX | XXX | XXX | XXX |
| Tactile Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Mesa Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Lumibird | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Anteris Technologies US M&A Activity
Anteris Technologies US acquired XXX companies to date.
Last acquisition by Anteris Technologies US was on XXXXXXXX, XXXXX. Anteris Technologies US acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Anteris Technologies US
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAnteris Technologies US Investment Activity
Anteris Technologies US invested in XXX companies to date.
Anteris Technologies US made its latest investment on XXXXXXXX, XXXXX. Anteris Technologies US invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Anteris Technologies US
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Anteris Technologies US
| When was Anteris Technologies US founded? | Anteris Technologies US was founded in 2024. |
| Where is Anteris Technologies US headquartered? | Anteris Technologies US is headquartered in United States. |
| How many employees does Anteris Technologies US have? | As of today, Anteris Technologies US has over 136 employees. |
| Who is the CEO of Anteris Technologies US? | Anteris Technologies US's CEO is Wayne G. Paterson. |
| Is Anteris Technologies US publicly listed? | Yes, Anteris Technologies US is a public company listed on Nasdaq. |
| What is the stock symbol of Anteris Technologies US? | Anteris Technologies US trades under AVR ticker. |
| When did Anteris Technologies US go public? | Anteris Technologies US went public in 2024. |
| Who are competitors of Anteris Technologies US? | Anteris Technologies US main competitors are BrainsWay, Tactile Medical, Mesa Laboratories, Perspective Therapeutics. |
| What is the current market cap of Anteris Technologies US? | Anteris Technologies US's current market cap is $537M. |
| What is the current revenue of Anteris Technologies US? | Anteris Technologies US's last 12 months revenue is $4M. |
| What is the current revenue growth of Anteris Technologies US? | Anteris Technologies US revenue growth (NTM/LTM) is 168%. |
| What is the current EV/Revenue multiple of Anteris Technologies US? | Current revenue multiple of Anteris Technologies US is 136.8x. |
| Is Anteris Technologies US profitable? | No, Anteris Technologies US is not profitable. |
| What is the current EBITDA of Anteris Technologies US? | Anteris Technologies US has negative EBITDA and is not profitable. |
| What is Anteris Technologies US's EBITDA margin? | Anteris Technologies US's last 12 months EBITDA margin is (2467%). |
| What is the current EV/EBITDA multiple of Anteris Technologies US? | Current EBITDA multiple of Anteris Technologies US is (5.5x). |
| What is the current FCF of Anteris Technologies US? | Anteris Technologies US's last 12 months FCF is ($89M). |
| What is Anteris Technologies US's FCF margin? | Anteris Technologies US's last 12 months FCF margin is (2309%). |
| What is the current EV/FCF multiple of Anteris Technologies US? | Current FCF multiple of Anteris Technologies US is (5.9x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.